L 6727 | CAS#77828-26-3 | bioactive chemical

MedKoo Cat#: 559091 | Name: L 6727

Description:

WARNING: This product is for research use only, not for human or veterinary use.

L 6727 is a bioactive chemical.

Chemical Structure

L 6727

CAS#77828-26-3

Theoretical Analysis

MedKoo Cat#: 559091

Name: L 6727

CAS#: 77828-26-3

Chemical Formula: C24H27I2NO3

Exact Mass: 631.0080

Molecular Weight: 631.29

Elemental Analysis: C, 45.66; H, 4.31; I, 40.20; N, 2.22; O, 7.60

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

L 6727; L-6727; L6727;

IUPAC/Chemical Name

(2-butylbenzofuran-3-yl)(4-(3-(dimethylamino)propoxy)-3,5-diiodophenyl)methanone

InChi Key

DPWAECJNVDGEFC-UHFFFAOYSA-N

InChi Code

InChI=1S/C24H27I2NO3/c1-4-5-10-21-22(17-9-6-7-11-20(17)30-21)23(28)16-14-18(25)24(19(26)15-16)29-13-8-12-27(2)3/h6-7,9,11,14-15H,4-5,8,10,12-13H2,1-3H3

SMILES Code

O=C(C1=C(CCCC)OC2=CC=CC=C12)C3=CC(I)=C(OCCCN(C)C)C(I)=C3

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 631.29 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: McMahon PB, Barlow JRB, Engle MA, Belitz K, Ging PB, Hunt AG, Jurgens BC, Kharaka YK, Tollett RW, Kresse TM. Methane and Benzene in Drinking-Water Wells Overlying the Eagle Ford, Fayetteville, and Haynesville Shale Hydrocarbon Production Areas. Environ Sci Technol. 2017 Jun 20;51(12):6727-6734. doi: 10.1021/acs.est.7b00746. Epub 2017 May 31. PubMed PMID: 28562061. 2: Xie FF, Pan SS, Ou RY, Zheng ZZ, Huang XX, Jian MT, Qiu JG, Zhang WJ, Jiang QW, Yang Y, Li WF, Shi Z, Yan XJ. Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer. Am J Cancer Res. 2015 Nov 15;5(12):3548-59. eCollection 2015. PubMed PMID: 26885445; PubMed Central PMCID: PMC4731630. 3: Abbou S, Lanvers-Kaminsky C, Daudigeos-Dubus E, LE Dret L, Laplace-Builhe C, Molenaar J, Vassal G, Geoerger B; within the ITCC Biology and Preclinical Evaluation Committee. Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric Malignancies. Anticancer Res. 2016 Feb;36(2):599-609. PubMed PMID: 26851014. 4: Xiao P, Huang Y, Yang W, Zhang B, Quan X. Screening lactic acid bacteria with high yielding-acid capacity from pickled tea for their potential uses of inoculating to ferment tea products. J Food Sci Technol. 2015 Oct;52(10):6727-6734. doi: 10.1007/s13197-015-1803-6. Epub 2015 Mar 20. PubMed PMID: 26396422; PubMed Central PMCID: PMC4573110. 5: Hou X, Wang L, Tang X, Xiong C, Guo Y, Liu X. Application of a β-cyclodextrin/graphene oxide-modified fiber for solid-phase microextraction of six fragrance allergens in personal products. Analyst. 2015 Oct 7;140(19):6727-35. doi: 10.1039/c5an01030f. Epub 2015 Sep 2. PubMed PMID: 26332186. 6: Peñuelas J, Farré-Armengol G, Llusia J, Gargallo-Garriga A, Rico L, Sardans J, Terradas J, Filella I. Removal of floral microbiota reduces floral terpene emissions. Sci Rep. 2014 Oct 22;4:6727. doi: 10.1038/srep06727. PubMed PMID: 25335793; PubMed Central PMCID: PMC4205883. 7: Geller F, Murillo R, Steinhauser L, Heinzmann B, Albert K, Merfort I, Laufer S. Four new flavonol glycosides from the leaves of Brugmansia suaveolens. Molecules. 2014 May 22;19(5):6727-36. doi: 10.3390/molecules19056727. PubMed PMID: 24858103. 8: Silva R, Fabry B, Boccaccini AR. Fibrous protein-based hydrogels for cell encapsulation. Biomaterials. 2014 Aug;35(25):6727-38. doi: 10.1016/j.biomaterials.2014.04.078. Epub 2014 May 15. Review. PubMed PMID: 24836951. 9: Lin CC, Su WC, Yen CJ, Hsu CH, Su WP, Yeh KH, Lu YS, Cheng AL, Huang DC, Fritsch H, Voss F, Taube T, Yang JC. A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies. Br J Cancer. 2014 May 13;110(10):2434-40. doi: 10.1038/bjc.2014.195. Epub 2014 Apr 22. PubMed PMID: 24755882; PubMed Central PMCID: PMC4021529. 10: Kashima Y, Miyazawa M. Chemical composition and aroma evaluation of essential oils from Evolvulus alsinoides L. Chem Biodivers. 2014 Mar;11(3):396-407. doi: 10.1002/cbdv.201300234. PubMed PMID: 24634069. 11: Schöffski P, Awada A, Dumez H, Gil T, Bartholomeus S, Wolter P, Taton M, Fritsch H, Glomb P, Munzert G. A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours. Eur J Cancer. 2012 Jan;48(2):179-86. doi: 10.1016/j.ejca.2011.11.001. Epub 2011 Nov 24. PubMed PMID: 22119200. 12: Stelfox HT, Ahmed SB, Zygun D, Khandwala F, Laupland K. Characterization of intensive care unit acquired hyponatremia and hypernatremia following cardiac surgery. Can J Anaesth. 2010 Jul;57(7):650-8. doi: 10.1007/s12630-010-9309-1. Epub 2010 Apr 20. PubMed PMID: 20405264. 13: Rudolph D, Steegmaier M, Hoffmann M, Grauert M, Baum A, Quant J, Haslinger C, Garin-Chesa P, Adolf GR. BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity. Clin Cancer Res. 2009 May 1;15(9):3094-102. doi: 10.1158/1078-0432.CCR-08-2445. Epub 2009 Apr 21. PubMed PMID: 19383823. 14: Solem C, Koebmann B, Yang F, Jensen PR. The las enzymes control pyruvate metabolism in Lactococcus lactis during growth on maltose. J Bacteriol. 2007 Sep;189(18):6727-30. Epub 2007 Jul 6. PubMed PMID: 17616595; PubMed Central PMCID: PMC2045170. 15: Gao P, Liu M. Compression induced helical nanotubes in a spreading film of a bolaamphiphile at the air/water interface. Langmuir. 2006 Aug 1;22(16):6727-9. PubMed PMID: 16863210. 16: Ruotolo BT, Gillig KJ, Woods AS, Egan TF, Ugarov MV, Schultz JA, Russell DH. Analysis of phosphorylated peptides by ion mobility-mass spectrometry. Anal Chem. 2004 Nov 15;76(22):6727-33. PubMed PMID: 15538797. 17: Krska R, Szente E, Freudenschuss M, Hametner C, Zöllner P. Purity assessment of commercially available crystalline deoxynivalenol. J AOAC Int. 2004 Jul-Aug;87(4):909-19. PubMed PMID: 15295885. 18: Matouschek A, Azem A, Ratliff K, Glick BS, Schmid K, Schatz G. Active unfolding of precursor proteins during mitochondrial protein import. EMBO J. 1997 Nov 17;16(22):6727-36. PubMed PMID: 9362487; PubMed Central PMCID: PMC1170277. 19: Li W, Chen XH, Kelley CA, Alimandi M, Zhang J, Chen Q, Bottaro DP, Pierce JH. Identification of tyrosine 187 as a protein kinase C-delta phosphorylation site. J Biol Chem. 1996 Oct 18;271(42):26404-9. PubMed PMID: 8824297. 20: Zhivotovsky LA, Feldman MW. Microsatellite variability and genetic distances. Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11549-52. PubMed PMID: 8524801; PubMed Central PMCID: PMC40439.